Follow the 삼성생명 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Banks sector, 삼성생명 has published 78 reports. Market capitalisation: €50,999.2bn. The latest transaction was reported on 24 April 2026 (Other). Among the most active insiders: 박민재. All data is free.
77
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성생명 Buy (bullish), based on 17 analysts. Average price target: ₩411,559.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,092 of 28,855 companies
59.0
score / 100
Value
69
Quality
49
FCF yld9.9%
Earn yld4.5%
EV/EBITDA9.2x
ROE5.3%
Gross mgn·
Net mgn8.1%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Samsung Life is a South Korean insurance company that provides various life insurance products and financial services. It is listed on the Korea Exchange, under the symbol XKRX.